Botulinum Toxin Injection Market Comprehensive Insight by Growth Rate, Industry Status, Forecast till 2027
The global botulinum toxin injection market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Botox or botulinum toxin is a drug made from a toxin that is produced by the bacterium clostridium botulinum and is used in small doses for the treatment of health problems such as temporary smoothing of facial wrinkles and improving appearance. The major factor for the growth of the market during the forecast period is the increasing demand for cosmetic non-invasive surgical procedures.
Moreover, the market is
growing due to new product launches. For instance, in July 2021, Allergan, an
AbbVie company announced the approval of a label expansion of BOTOX by the US
Food and Drug Administration (FDA) to include eight new muscles for the
treatment of upper limb spasticity in adults. Furthermore, the ongoing R&D
is further expected to boost the growth of the market. For instance, as per UC
SanDiego Health, researchers at Skaggs School of Pharmacy and Pharmaceutical
Sciences at the University of California San Diego, in collaboration with two
physicians from Germany with help of the US FDA’s Adverse Effect Reporting
System (FAERS) database found that the Botox Injections may reduce anxiety in
2021, which in turn is driving the growth of the market.
To Request a Sample of our Report on Botulinum Toxin
Injection Market: https://www.omrglobal.com/request-sample/botulinum-toxin-injection-market
Some major players in the market include Ipsen Pharma,
Revance Therapeutics Inc., and AbbVie Inc. (Allergan plc), among others. The
market players are contributing significantly to the growth of the market by
the adoption of various strategies including mergers & acquisitions,
geographical expansion, partnerships and collaborations, and new product
launches, to stay competitive in the market. For instance, in December 2020,
Ajinomoto Bio-Pharma Services and Revance Therapeutics announced a strategic
commercial manufacturing agreement. The agreement was aimed at the supply of
DaxibotulinumtoxinA for Injection.
Market Coverage
• The market number available for –
2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered-
·
By Application
·
By Type
·
By End-User
• Regions
Covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
•
Competitive Landscape- Ipsen Pharma,
Revance Therapeutics Inc., and AbbVie Inc. (Allergan plc), among others.
(Get 15% Discount on Buying this Report)
A
full Report of Botulinum Toxin Injection Market is Available @ https://www.omrglobal.com/industry-reports/botulinum-toxin-injection-market
Global Botulinum Toxin Injection Market Report Segment
By Application
• Therapeutics
o Chronic
Migraine
o Spasticity
o Overactive
Bladder
o Cervical
Dystonia
o Blepharospasm
o Others
• Aesthetics
By Type
• Botulinum Toxin Type A
• Botulinum Toxin Type B
By End-User
• Specialty & Dermatology Clinics
• Hospitals & Clinics
• Others
Global Botulinum Toxin Injection Market Report Segment
by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment